ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

4.20
0.08
(1.94%)
마감 17 2월 6:00AM
4.26
0.06
(1.43%)
시간외 거래: 9:58AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
4.26
매수가
4.21
매도가
4.33
거래량
1,584,334
4.10 일간 변동폭 4.35
4.045 52주 범위 11.555
market_cap
전일 종가
4.12
개장가
4.16
최근 거래 시간
250
@
4.26
(formt)
마지막 거래 시간
재정 규모
US$ 6,679,067
VWAP
4.2157
평균 볼륨(3m)
1,833,508
발행 주식
252,527,585
배당수익률
-
주가수익률
-8.93
주당순이익(EPS)
-0.47
매출
292.23M
순이익
-119.03M

Maravai LifeSciences Holdings Inc 정보

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
본부
Wilmington, Delaware, USA
설립됨
-
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker MRVI. The last closing price for Maravai LifeSciences was US$4.12. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 4.045 to US$ 11.555.

Maravai LifeSciences currently has 252,527,585 shares in issue. The market capitalisation of Maravai LifeSciences is US$1.04 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -8.93.

MRVI 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.65-13.23828920574.914.984.04525981894.26664938CS
4-0.34-7.391304347834.66.054.04520616554.81866285CS
12-0.78-15.47619047625.046.214.04518335085.1692416CS
26-4.23-49.82332155488.499.954.04519743726.70382102CS
52-0.95-18.23416506725.2111.5554.04522074047.52532157CS
156-24.21-85.036880927328.4741.824.045210665713.40710731CS
260-26.85-86.306653809131.1163.554.045192277018.96545514CS

MRVI - Frequently Asked Questions (FAQ)

What is the current Maravai LifeSciences share price?
The current share price of Maravai LifeSciences is US$ 4.26
How many Maravai LifeSciences shares are in issue?
Maravai LifeSciences has 252,527,585 shares in issue
What is the market cap of Maravai LifeSciences?
The market capitalisation of Maravai LifeSciences is USD 1.04B
What is the 1 year trading range for Maravai LifeSciences share price?
Maravai LifeSciences has traded in the range of US$ 4.045 to US$ 11.555 during the past year
What is the PE ratio of Maravai LifeSciences?
The price to earnings ratio of Maravai LifeSciences is -8.93
What is the cash to sales ratio of Maravai LifeSciences?
The cash to sales ratio of Maravai LifeSciences is 3.64
What is the reporting currency for Maravai LifeSciences?
Maravai LifeSciences reports financial results in USD
What is the latest annual turnover for Maravai LifeSciences?
The latest annual turnover of Maravai LifeSciences is USD 292.23M
What is the latest annual profit for Maravai LifeSciences?
The latest annual profit of Maravai LifeSciences is USD -119.03M
What is the registered address of Maravai LifeSciences?
The registered address for Maravai LifeSciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Which industry sector does Maravai LifeSciences operate in?
Maravai LifeSciences operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
JTAIJet AI Inc
US$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
US$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
425.19k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.01M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
160.99k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.07M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
480.49M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
411.17M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
248.48M
INTCIntel Corporation
US$ 23.60
(-2.20%)
225.04M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
189.56M

MRVI Discussion

게시물 보기
Monksdream Monksdream 12 월 전
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 12 월 전
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 4 년 전
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 4 년 전
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 4 년 전
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

최근 히스토리

Delayed Upgrade Clock